Benjamin J. Hindson - 28 Dec 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Scientific Officer and President, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Issuer symbol
TXG
Transactions as of
28 Dec 2021
Net transactions value
+$129,690
Form type
4
Filing time
30 Dec 2021, 18:31:35 UTC
Previous filing
03 Dec 2021
Next filing
05 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Options Exercise $57,729 +53,952 +115% $1.07* 100,718 28 Dec 2021 Direct
transaction TXG Class A Common Stock Options Exercise $71,962 +59,968 +60% $1.20* 160,686 28 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Stock Option (right to buy) Options Exercise $0 -53,952 -100% $0.000000* 0 28 Dec 2021 Class A Common Stock 53,952 $1.07 Direct F1
transaction TXG Stock Option (right to buy) Options Exercise $0 -59,968 -100% $0.000000* 0 28 Dec 2021 Class A Common Stock 59,968 $1.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All of the shares subject to the option are fully vested and exercisable as of the date hereof.

Remarks:

Chief Scientific Officer and President